Either the tetracyclic and the tricyclic derivatives in Figure 12 and Figure 13 are claimed as useful inhibitors of HIVs by targeting their IN enzymes [132,133] and thus useful for the management of HIV infections and/or reduction of the severity of symptoms of HIV infection in cell-based systems [132,133]. This evidence concerns the gene CD44 and HIV infectious disease.